Pharma Pulse 8/14/24: Brands Love Influencers...Until Politics Get Involved, Improving Pain Self-Management Among Rural, Older Cancer Patients & more

A Look into Promising AstraZeneca Oncology Agents

In an interview with Pharm Exec Associate Editor Don Tracy, Carlos Doti, VP, Head of Medical Affairs, US Oncology Business Unit, AstraZeneca, discusses a number of oncology targets in the works at AstraZeneca.

Improving Pain Self-Management Among Rural, Older Cancer Patients

The management of pain in older adults with cancer remains a significant public health concern and an unmet medical need, particularly in rural areas. This demographic often encounters specific challenges, such as limited access to healthcare services, hesitancy to talk about pain, and misunderstandings about pain management.

Brands Love Influencers (Until Politics Get Involved)

Marketing firms are using artificial intelligence to help analyze influencers and predict whether they will opine about the election.

Modern Health Selected To Prestigious Inc. 5000 List of America’s Fastest-Growing Private Companies

Inc. revealed that Modern Health has been selected to the 2024 Inc. 5000, its annual list of the fastest-growing private companies in America. The prestigious ranking provides a data-driven look at the most successful companies within the economy’s most dynamic segment—its independent, entrepreneurial businesses. Microsoft, Meta, Chobani, Under Armour, Timberland, Oracle, Patagonia, and many other household-name brands gained their first national exposure as honorees on the Inc. 5000.

Nicholas Saraceno on LinkedIn

And just like that, another issue of Pharma Commerce is in the books. Our August issue does a wonderful job of covering the below, alongside an examination of Big Pharma Inventories and a look at the US drug wholesaling market.

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs